ホーム › フォーラム一覧 › 「米国での投資」お役立ちフォーラム › CNBC「Mad Money」エピソードのまとめ › Mad Money: January 16, 2020 (Thursday) Key Points
- このトピックは空です。
-
投稿者投稿
-
-
2020年1月16日 11:00 PM #3017
暮眞★潤 (Jun Kurema)
キーマスターMicrosoft’s plan to be carbon negative by 2030 ‘is not greenwash,’ Jim Cramer says (https://www.cnbc.com/2020/01/16/microsofts-carbon-negative-by-2030-is-not-greenwash-jim-cramer-says.html)
- Microsoft plans to be carbon negative by 2030 and has another ambitious goal set for 2050.
- “I think they can do it because, remember, they are a powerful force — maybe the most powerful, especially when it comes to data centers, of almost any company on Earth,” CNBC’s Jim Cramer said.
- “So I think they can make an impact. I think this is real. This is not greenwash,” the “Mad Money” host said.
Ticker: MSFT, AMZN
Executive Interview: Capitalism ‘will fundamentally be in jeopardy’ if business does not act on climate change, Microsoft CEO Satya Nadella says (https://www.cnbc.com/2020/01/16/microsoft-ceo-capitalism-is-in-jeopardy-if-we-do-not-act-on-climate-change.html)
- “The corporation’s purpose is to find profitable solutions to the problems of people and planet,” Microsoft CEO Satya Nadella told CNBC.
- ″‘Profitable’ is the key word, but ‘problems’ is the other key word for people and planet,” he said in a “Mad Money” interview.
- Microsoft CFO Amy Hood said the software giant’s commitment to being carbon negative by 2030 and its affordable housing initiatives “are good return investments.”
Executive Interview: Microsoft CEO and CFO talk getting a return on investment from sustainability projects (https://www.cnbc.com/video/2020/01/16/microsoft-ceo-cfo-on-getting-a-return-on-investment-in-sustainability.html)
Executive Interview: FDA-backed CBD drug brings in $296 million in ‘incredible launch year,’ GW Pharma CEO says (https://www.cnbc.com/2020/01/16/cbd-epilepsy-drug-does-incredible-296-million-in-sales-gw-pharma-ceo.html)
- “It’s an incredible launch year for any medication [that] I think proves that this kind of medicine is really making a difference to patients,” GW Pharma CEO Justin Gover said after selling $296 million worth of Epidiolex in 2019.
- “It shows real value to the health-care system, and it sets us up, I think, in a very nice way for what should be another great year for us in 2020,” he said in a “Mad Money” interview.
- Epidiolex is the first CBD-based epilepsy treatment launched in the United States.
Ticker: GWPH,
Cramer’s lightning round: Inogen is ‘in the penalty box’ (https://www.cnbc.com/2020/01/16/cramer-lightning-round-inogen-is-in-the-penalty-box.html)
- JD.com: “We don’t need JD … because we’ve got Alibaba. Now they’re both up a lot, but I like Alibaba very much.”
- Adverum Biotechnologies: “Well look, this is the kind of speculative I like and I encourage. I encourage this kind of speculation on Mad Money because as long as you don’t put too much money in it, maybe this is the home run. Don’t put too much money in it and it can work.”
- Inogen: “They missed the numbers really big. Now that means they’re in the penalty box. I need to see not one but two quarters before I’d be willing to buy that. That was a terrible miss, it deserved to go down.”
- Trade Desk: “That company is miraculous, it’s terrific.”
- Stag Industrial: “The industrial REITs are really the only REITs right now that are actually working, and they’re working phenomenally.”
Ticker: JD, ADVM, INGN, TTD, STAG
本トピックに関する質問、コメントは親フォーラム「米国での投資」お役立ちフォーラムから新規トピックとしてご投稿ください。
-
-
投稿者投稿
- トピック「Mad Money: January 16, 2020 (Thursday) Key Points」には新しい返信をつけることはできません。